Report Highlights
The global market for spatial genomics and transcriptomics is estimated to increase from $1.5 billion in 2022 to reach $2.5 billion by 2027, at a compound annual growth rate (CAGR) of 10.8% from 2022 through 2027.
Report Includes
- 34 data tables and 30 additional tables
- An overview of the global spatial genomics and transcriptomics market
- Analyses of global market trends with data from 2020-2022, and projections of compound annual growth rates (CAGRs) through 2027
- Estimation of the market size and highlights of the market potential by technology, end user, and application
- Detailed description of fluorescence In situ hybridization and microscopy RNA imaging and discussion on their application in the genomics industry
- Assessment of the current market size and forecast of market development in the coming five years, and insight into the value chain analysis, and factors driving and restraining the growth
- Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the global spatial genomics and transcriptomics market
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues
- Company profiles of the leading global players, including Advanced Cell Diagnostics Inc., Bruker, Illumina, Standard BioTools Inc., Vizgen and Lunaphore
Report Scope
This report incorporates an in-depth analysis of the spatial genomics and transcriptomics market, including market estimations and trends through 2021. Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The product analysis focuses on recent technological trends in various regions, such as the U.S., Europe, and Japan. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for spatial genomics and transcriptomics technologies.
The scope of the report covers only those spatial genomics and transcriptomics technologies that generate the most global revenue. Spatial genomics and transcriptomics are similar to spatial biology.
This report segments the global market by the geographic regions of North America, Europe, Asia-Pacific and the Rest of the World. For market estimates, data are provided for 2021 as the base year and forecast through the end of 2027.
Report Synopsis
| Report Metrics | Details | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||
| Forecast period considered | 2022-2027 | ||||||||||||
| Base year market size | $1.4 billion | ||||||||||||
| Market size forecast | $2.5 billion | ||||||||||||
| Growth rate | CAGR of 10.8% for the forecast period of 2022-2027 | ||||||||||||
| Units considered | $ Millions | ||||||||||||
| Segments covered | region, application, end user, product, transcriptomics, genomics, and technology | ||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World | ||||||||||||
| Countries covered | United States, Mexico, Canada, France, Germany, Italy, Spain, United Kingdom, China, Japan, and India | ||||||||||||
| Key Market Drivers |
|
||||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
- Rise in Geriatric Population and chronic diseases
- Antibody-Based Drug Discovery and Development
- Relationship with leading Biopharma and life science tools.
- 10xGenomics
- Bruker
- Akoya Biosciences, Inc.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Bioinformatics: Technologies and Global Markets
The global market for bioinformatics is expected to grow from $18.7 billion in 2023 to $35.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 13.6% during the forecast period of 2023-2028.
RNA Sequencing: Technologies and Global Markets
The global RNA-Sequencing market should reach nearly $2.1 billion in 2020, from over $1.0 billion in 2015 registering a compound annual growth rate (CAGR) of 14.9%.
Recent Reports
Exosome Diagnostics, Therapeutics and Research Tools: Global Markets
The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.
Peptide Synthesis: Global Markets
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.
Oligonucleotides: Global Markets
The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
Viral Vector and Plasmid DNA: Technologies and Global Markets
The global market for viral vector and plasmid DNA technologies is expected to grow from $2.9 billion in 2023 to $7.1 billion by the end of 2028, at a compound annual growth rate (CAGR) of 19.7% from 2023 through 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
Flame Retardant Chemicals: Technologies and Global Markets
The global consumption of flame retardant chemicals is estimated to grow from 6.0 billion pounds in 2022 to 7.5 billion pounds in 2027, at a compound annual growth rate (CAGR) of 4.4% for the period of 2022-2027.
Biorefinery Products: Global Markets
The global market for biorefinery products is estimated to increase from $624.7 billion in 2022 to $920.0 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.
Electric Vehicle Charging: Infrastructure and Global Markets
The global market for wired electric vehicle charging infrastructure is estimated to grow from $24.1 billion in 2022 to $81.1 billion in 2027, at a compound annual growth rate (CAGR) of 27.4% for the period of 2022-2027.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More